MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/ijem.ijem_81_24

Медицинская библиотека · Indian journal of endocrinology and metabolism · 2025

Role of Anabolic Anti-Osteoporosis Therapy in Diabetes Subjects.

Durgia Harsh, Palui Rajan, Sahoo Jayaprakash, Kamalanathan Sadishkumar, Naik Dukhabandhu

СтатьяОбзорПеревод в очереди

Аннотация

Diabetes mellitus (DM) is a metabolic disorder that leads to the destruction of various tissues including bones. The pathogenesis of osteoporosis (OP) varies in DM due to many specific factors. DM increases the risk of fracture as well as post-fracture mortality. It is because of this fact that OP treatment should not be neglected in patients with DM. OP therapy comprises anabolic as well as anti-resorptive agents. Primary OP as observed in post-menopausal women is associated with high bone turnover, whereas OP in DM is a disease of low bone turnover. Therefore, anabolic agents seem to be quite promising in cases of OP in DM. Although the anti-fracture efficacy of these drugs is proven beyond any doubt in the general population without DM, evidence in persons with DM is limited. Among the anabolic agents, teriparatide has the most evidence in favor of its efficacy and safety in persons with DM. Studies evaluating other anabolic agents such as abaloparatide and romosozumab in diabetic osteopathy are scarce in the literature. Future studies specifically in both type 1 and type 2 DM populations are needed to evaluate the effects of osteoanabolic agents.

Для цитирования: Durgia Harsh, Palui Rajan, Sahoo Jayaprakash, Kamalanathan Sadishkumar, Naik Dukhabandhu. Role of Anabolic Anti-Osteoporosis Therapy in Diabetes Subjects.. Indian journal of endocrinology and metabolism. 2025. DOI: 10.4103/ijem.ijem_81_24.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.